A Benchmark for Dose Finding Studies with Continuous Outcomes

November 27, 2018, by Pamela Forster

Pavel Mozgunov, Thomas Jaki & Xavier Paoletti. 6th Early Phase Adaptive Trials Workshop, Los Angeles, USA (November 2018)

A robust Bayesian hierarchical model to incorporate preclinical animal data into a phase I dose-escalation trial

, by Pamela Forster

Haiyan Zheng, Lisa Hampson & Simon Wandel, 6th Early Phase Adaptive Trials Workshop, Los Angeles, USA (November 2018)

Information Theory in Dose-Finding: Improving Safety of the CRM

, by Pamela Forster

Thomas Jaki & Pavel Mozgunov, 6th Early Phase Adaptive Trials Workshop, Los Angeles, USA (November 2018).

An ethical non-parametric design for selecting arms in a multi-arm clinical trial

August 28, 2018, by Pamela Forster

Thomas Jaki & Pavel Mozgunov, International Society for Clinical Biostatistics (ISCB) 2018, Melbourne, Australia

A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay

August 21, 2018, by Pamela Forster

Eleni Vradi, Werner Brannath, Thomas Jaki & Richard Vonk. IBC (2018), Barcelona.

Incorporating historical information in biosimilar trials

, by Pamela Forster

Johanna Miekle, Heidi Schmidli & Byron Jones. IBC 2018 (Barcelona, Spain).

An information-theoretic Phase I/II design for molecularly targeted agents that does not require an assumption of monotonicity

August 10, 2018, by Pamela Forster

Pavel Mozgunov & Thomas Jaki. IBC 2018, Barcelona, Spain

A Bayesian hierarchical model to incorporate pre-clinical data from multiple species into a phase I first-in-man trial

, by Pamela Forster

Haiyan Zheng, Lisa Hampson & Simon Wandel. IBC (2018), Barcelona

About IDEAS: What’s the Big Idea?

July 12, 2018, by Pamela Forster

An overview of the objectives and training of the IDEAS Network. Presented at IBC 2018 (Barcelona) and ISCB 2018 (Melbourne)

A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay

June 12, 2018, by Pamela Forster

Eleni Vradi, Thomas Jaki, Werner Brannath & Ricahard Vonk. PSI, 4th June 2018 (Amsterdam)